Content about Tablet

NEW YORK — A new network allows customers to use tablets to participate in customer loyalty programs, according to published reports.

MediaPost reported that SpotOn, a San Rafael, Calif.-based company that develops customer loyalty platforms, rolled out its network Friday, with about 1,500 independent and regional chain retailers; the network had previously been under development for more than a year. Most of the retailers are in the Atlanta area, Texas, Arizona, California and the Midwest, but that it's adding about 500 new ones per month.

NEW YORK — More than three-quarters of U.S. smartphone and tablet owners have used their mobile devices for shopping-related activities, according to a recent Nielsen survey.

FREIENBACH, Switzerland — The Food and Drug Administration approved an effervescent tablet for treating osteoporosis.

EffRx Pharmaceuticals announced the FDA approval of Binosto (alendronate sodium), a strawberry-flavored tablet designed to dissolve in water that the company called the first treatment of its kind. The drug is designed to treat osteoporosis in menopausal women and increase bone mass in men with osteoporosis. EffRx expects to launch Binosto in third quarter 2012.

WASHINGTON — A survey released Thursday by the National Retail Federation found that nearly one-third of tablet owners will use the device to purchase back-to-school items.

According to NRF’s 2011 Back-to-School and College surveys conducted by BIGresearch, consumers with smartphones and tablets will use their devices to research products, redeem coupons, look up store information and even make purchases.

DALLAS — Aspirinpod recently launched its Aspirinpod emergency aspirin container — a small heart-shaped container that can be carried on a key chain.

Aspirinpod is a reminder to have aspirin with you at all times in the event of a heart attack, noted company founder Patti Frenette.

The small container, which does not include the aspirin, is large enough for two 325-mg tablets or four 81-mg tablets. Suggested retail price is $2.99.

LOS ANGELES Standard Homeopathic Co., which manufactures homeopathic products under the Hyland’s brand in mass retail, on Saturday recalled its Hyland’s teething tablets “in an abundance of caution due to an FDA investigation of its manufacturing facility,” the company stated.